CTI BioPharma (NASDAQ:CTIC) Hits New 12-Month High at $9.08

CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating)’s stock price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $9.08 and last traded at $9.08, with a volume of 202576 shares changing hands. The stock had previously closed at $9.07. Analyst Ratings Changes Several brokerages recently issued reports […]

Related Keywords

Zurcher Kantonalbank Zurich Cantonalbank ,Stifel Nicolaus ,Fund Management Co ,Proshare Advisors ,Pricet Rowe Associates Inc ,Principal Financial Group Inc ,Biopharma Corp ,Needham Company ,Nasdaq ,Cti Biopharma Corp ,Get Rating ,Pharma Stock ,Share Advisors ,Fund Management ,Financial Group ,Kantonalbank Zurich Cantonalbank ,Pharma Daily ,